Results 101 to 110 of about 61,156 (193)

Patient navigation as a core component of global cancer care—A call to action from the Global Alliance for Cancer Patient Navigation

open access: yesCancer, Volume 132, Issue 16, 15 August 2026.
Abstract Patient navigation is generally defined as an individualized service that breaks down barriers to provide comprehensive and equitable cancer care. As the evidence base grows for patient navigation efficacy in diverse settings across the cancer continuum, navigation is increasingly recognized and adopted as an essential resource to aid in ...
Anurag K. Agrawal   +20 more
wiley   +1 more source

Optimizing safety and efficacy of asparaginase and blinatumomab therapy in frontline acute lymphoblastic leukemia regimens in diverse health care settings—international expert consensus

open access: yesCancer, Volume 132, Issue 16, 15 August 2026.
ABSTRACT Frontline blinatumomab combined with chemotherapy has resulted in improved outcomes in both pediatric and adult patients with acute lymphoblastic leukemia and is considered the new cornerstone of acute lymphoblastic leukemia treatment. The role of asparaginase in this new landscape of acute lymphoblastic leukemia treatment was extensively ...
Daniel J. DeAngelo   +15 more
wiley   +1 more source

Pull‐and‐Push Nanotherapeutic Hydrogels: Scavenging Inflammatory Triggers While Driving Tissue Regeneration in Burn Wounds

open access: yesAdvanced Functional Materials, Volume 36, Issue 63, 6 August 2026.
A nanounit‐assembled hydrogel employing a “pull‐and‐push” strategy simultaneously scavenges pro‐inflammatory cell‐free DNA (cfDNA) and delivers regenerative therapeutics in response to burn‐induced hyperthermia. By repolarizing macrophages and promoting angiogenesis, this multifunctional platform accelerates burn wound healing, offering a blueprint for
Han‐Sem Kim   +9 more
wiley   +1 more source

Long‐Term Effects of a Dietary Humic Substance–Butyrate Blend, and Yeast Cell Wall on Growth Performance, Immune Status and Gut Microbiota of Juvenile Channel Catfish Ictalurus punctatus

open access: yesAquaculture, Fish and Fisheries, Volume 6, Issue 4, August 2026.
ABSTRACT This study evaluated the long‐term effects of a dietary humic substance and butyrate blend (HSB) alone or with yeast cell wall (Beta‐MOS) in channel catfish. Around 1440 fish (31.31 ± 0.24 g) were distributed among 12 outdoor tanks in a pond‐supplied flow‐through design. Four dietary treatments were evaluated in triplicate: Diets containing no
Abdulmalik A. Oladipupo   +5 more
wiley   +1 more source

Single‐Stage Anatomic Reconstruction of Anterior Cruciate Ligament, Posterior Cruciate Ligament, Medial Collateral Ligament, and Posterolateral Corner for Multiligament Knee Injury

open access: yesArthroscopy Techniques, Volume 15, Issue 8, August 2026.
Abstract Multiligament knee injuries represent rare and challenging injuries that require complex surgical management to restore stability and function. Current evidence supports anatomic single‐stage reconstructions when feasible in order to re‐establish knee kinematics and enable early rehabilitation.
Logan D. Moews   +6 more
wiley   +1 more source

Arthroscopic Segmental Labral Reconstruction Using a Presutured Iliotibial Band Allograft Soaked in Bone Marrow Aspirate Concentrate

open access: yesArthroscopy Techniques, Volume 15, Issue 8, August 2026.
Abstract Labral reconstruction is a surgical procedure in which a graft is used to replace irreparable acetabular labral tissue. Biologic augmentation with bone marrow aspirate concentrate harvested from the ipsilateral iliac crest is increasingly used to enhance graft incorporation and potentially improve functional outcomes, especially in patients ...
Jacob D. Kodra   +7 more
wiley   +1 more source

Chronic Recurrent Multifocal Osteomyelitis in a Pediatric Patient: An Uncommon Case With Diagnostic Challenge

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Chronic Recurrent Multifocal Osteomyelitis (CRMO) is a rare autoinflammatory bone disorder that primarily affects children and adolescents. It is characterized by recurrent episodes of bone pain with sterile inflammatory lesions, often resembling infection or malignancy.
Dosti Regmi   +4 more
wiley   +1 more source

Transforming academia for equity: implementation at the University of Memphis. [PDF]

open access: yesFront Public Health
Levy M   +9 more
europepmc   +1 more source

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5‐HT3 Receptor Antagonists: 2026 Update

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 2, Page 387-393, August 2026.
5‐hydroxytryptamine type 3 (5‐HT3) receptor antagonists are used to treat nausea and vomiting and in the prevention of chemotherapy‐induced, radiation‐induced, and postoperative nausea and vomiting. Most of the 5‐HT3 receptor antagonists (i.e., ondansetron, tropisetron, dolasetron, palonosetron, and ramosetron) are metabolized by CYP2D6, but the extent
Claire Moore   +16 more
wiley   +1 more source

Characterization of Genetic Etiologic Factors for Pediatric Acute Lymphoblastic Leukemia in Large Childhood Cancer Survivorship Cohorts. [PDF]

open access: yesCancer Epidemiol Biomarkers Prev
Meng X   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy